November 3, 2023 10:55 AM EDT
News Briefing

Out­look to con­duct an­oth­er tri­al for wet AMD drug; Cara strikes new roy­al­ty deal

Jaimy Lee

Deputy Editor

Out­look to con­duct an­oth­er tri­al for eye drug af­ter re­jec­tion: Out­look Ther­a­peu­tics an­nounced Thurs­day that the FDA wants an ad­di­tion­al study …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times